When did BIOLIFE SOLUTIONS INC (BLFS) report earnings last quarter?
BIOLIFE SOLUTIONS INC (BLFS) last reported earnings on 2/26/2026.
NASDAQ:BLFS • US09062W2044
Past quarterly earnings results for BIOLIFE SOLUTIONS INC (BLFS), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 0.22 | -0.02 | 1,095.32% | -15.38% | 24.764M | 24.564M | 0.81% | 9.03% |
| Q3 2025 | 0.01 | -0.01 | 184.01% | 125.00% | 28.067M | 26.207M | 7.10% | -8.19% |
| Q2 2025 | -0.01 | -0.04 | 72.55% | 98.00% | 25.421M | 24.184M | 5.11% | -10.26% |
| Q1 2025 | -0.01 | -0.05 | 81.45% | 95.65% | 23.941M | 22.666M | 5.63% | -24.54% |
| Q4 2024 | 0.26 | -0.07 | 496.49% | 186.67% | 22.713M | 21.978M | 3.34% | -30.61% |
| Q3 2024 | -0.04 | -0.09 | 55.00% | 86.67% | 30.571M | 26.048M | 17.36% | -8.27% |
| Q2 2024 | -0.50 | -0.14 | -246.60% | -117.39% | 28.328M | 24.425M | 15.98% | -28.30% |
| Q1 2024 | -0.23 | -0.29 | 19.47% | 28.13% | 31.727M | 26.527M | 19.60% | -15.85% |
| Q4 2023 | -0.30 | -0.35 | 13.92% | 73.91% | 32.732M | 34.067M | -3.92% | -26.05% |
| Q3 2023 | -0.30 | -0.38 | 21.57% | -30.43% | 33.328M | 33.668M | -1.01% | -18.21% |
| Q2 2023 | -0.23 | -0.20 | -12.75% | -283.33% | 39.508M | 44.737M | -11.69% | -2.52% |
| Q1 2023 | -0.32 | -0.22 | -48.38% | -88.24% | 37.703M | 43.802M | -13.92% | 4.09% |
| Q4 2022 | -1.15 | -0.17 | -576.46% | -210.81% | 44.26M | 44.151M | 0.25% | 18.63% |
| Q3 2022 | -0.23 | -0.17 | -32.64% | - | 40.75M | 42.905M | -5.02% | 20.56% |
| Q2 2022 | -0.06 | -0.22 | 72.55% | 50.00% | 40.53M | 39.965M | 1.41% | 29.90% |
| Q1 2022 | -0.17 | -0.25 | 32.43% | -466.67% | 36.22M | 38.968M | -7.05% | 114.96% |
| Q4 2021 | -0.37 | -0.17 | -115.19% | -516.67% | 37.31M | 36.53M | 2.14% | 153.29% |
| Q3 2021 | 0.00 | -0.09 | 100.00% | 100.00% | 33.8M | 32.242M | 4.83% | 199.65% |
| Q2 2021 | -0.12 | -0.07 | -76.46% | 82.86% | 31.2M | 28.104M | 11.02% | 214.52% |
| Q1 2021 | -0.03 | -0.04 | 23.27% | -200.00% | 16.85M | 16.37M | 2.93% | 38.57% |
| Q4 2020 | -0.06 | -0.02 | -174.49% | - | 14.73M | 13.767M | 6.99% | - |
| Q3 2020 | -0.08 | -0.02 | -327.89% | - | 11.28M | 11.034M | 2.23% | - |
| Q2 2020 | -0.70 | -0.04 | -1,860.78% | - | 9.92M | 9.76M | 1.64% | - |
| Q1 2020 | -0.01 | -0.02 | 39.67% | - | 12.16M | 10.921M | 11.35% | - |
Notes
BIOLIFE SOLUTIONS INC (BLFS) last reported earnings on 2/26/2026.
BIOLIFE SOLUTIONS INC (BLFS) beat EPS estimates and beat revenue estimates in the most recent quarter.
In the last 4 quarters, BIOLIFE SOLUTIONS INC (BLFS) has beaten EPS estimates in 4 out of 4 releases.